First Light Asset Management as of March 31, 2015
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 62 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 7.4 | $15M | 706k | 20.49 | |
| NeoGenomics (NEO) | 7.1 | $14M | 3.0M | 4.67 | |
| Akorn | 6.2 | $12M | 256k | 47.51 | |
| Harvard Bioscience (HBIO) | 4.6 | $9.1M | 1.6M | 5.82 | |
| Spectranetics Corporation | 4.0 | $7.9M | 228k | 34.76 | |
| RTI Biologics | 3.9 | $7.7M | 1.6M | 4.94 | |
| NxStage Medical | 3.6 | $7.1M | 412k | 17.30 | |
| Ligand Pharmaceuticals In (LGND) | 3.6 | $7.0M | 91k | 77.11 | |
| IGI Laboratories | 3.4 | $6.6M | 806k | 8.16 | |
| Tearlab Corp | 3.0 | $5.9M | 3.0M | 1.99 | |
| Oxford Immunotec Global | 3.0 | $5.8M | 410k | 14.08 | |
| Array BioPharma | 2.9 | $5.7M | 776k | 7.37 | |
| Endologix | 2.4 | $4.7M | 277k | 17.07 | |
| Celldex Therapeutics | 2.4 | $4.7M | 169k | 27.87 | |
| Omnicell (OMCL) | 2.4 | $4.7M | 134k | 35.10 | |
| Insmed (INSM) | 2.2 | $4.4M | 210k | 20.80 | |
| Bio-techne Corporation (TECH) | 2.2 | $4.3M | 43k | 100.29 | |
| Quidel Corporation | 2.2 | $4.3M | 158k | 26.98 | |
| Novadaq Technologies | 2.0 | $4.0M | 244k | 16.24 | |
| Enzo Biochem (ENZB) | 2.0 | $3.9M | 1.3M | 2.95 | |
| AngioDynamics (ANGO) | 2.0 | $3.8M | 216k | 17.79 | |
| D Fluidigm Corp Del (LAB) | 1.9 | $3.8M | 90k | 42.10 | |
| Streamline Health Solutions | 1.8 | $3.5M | 996k | 3.55 | |
| Lannett Company | 1.7 | $3.4M | 50k | 67.71 | |
| Veracyte (VCYT) | 1.6 | $3.2M | 440k | 7.28 | |
| BioMarin Pharmaceutical (BMRN) | 1.6 | $3.1M | 25k | 124.60 | |
| Alkermes (ALKS) | 1.5 | $3.0M | 50k | 60.97 | |
| Cepheid | 1.4 | $2.8M | 50k | 56.91 | |
| STAAR Surgical Company (STAA) | 1.3 | $2.5M | 341k | 7.43 | |
| LeMaitre Vascular (LMAT) | 1.2 | $2.4M | 292k | 8.38 | |
| HealthStream (HSTM) | 1.2 | $2.3M | 92k | 25.20 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $2.3M | 19k | 117.94 | |
| AMAG Pharmaceuticals | 1.1 | $2.2M | 41k | 54.65 | |
| Bluebird Bio | 1.1 | $2.1M | 18k | 120.78 | |
| Verastem | 1.1 | $2.1M | 208k | 10.17 | |
| Sunopta (STKL) | 0.8 | $1.6M | 147k | 10.62 | |
| Cytokinetics (CYTK) | 0.7 | $1.3M | 199k | 6.78 | |
| Aratana Therapeutics | 0.5 | $1.0M | 64k | 16.01 | |
| Endo International | 0.4 | $732k | 8.2k | 89.69 | |
| United Therapeutics Corporation (UTHR) | 0.3 | $659k | 3.8k | 172.51 | |
| Humana (HUM) | 0.3 | $630k | 3.5k | 177.97 | |
| Anthem (ELV) | 0.3 | $632k | 4.1k | 154.33 | |
| Novartis (NVS) | 0.3 | $599k | 6.1k | 98.68 | |
| Actavis | 0.3 | $606k | 2.0k | 297.79 | |
| Mylan Nv | 0.3 | $580k | 9.8k | 59.34 | |
| Aetna | 0.3 | $556k | 5.2k | 106.62 | |
| Bristol Myers Squibb (BMY) | 0.3 | $535k | 8.3k | 64.54 | |
| Becton, Dickinson and (BDX) | 0.2 | $487k | 3.4k | 143.45 | |
| Celgene Corporation | 0.2 | $493k | 4.3k | 115.19 | |
| Steris Corporation | 0.2 | $445k | 6.3k | 70.30 | |
| Johnson & Johnson (JNJ) | 0.2 | $384k | 3.8k | 100.52 | |
| Eli Lilly & Co. (LLY) | 0.2 | $399k | 5.5k | 72.61 | |
| AstraZeneca (AZN) | 0.2 | $389k | 5.7k | 68.49 | |
| St. Jude Medical | 0.2 | $396k | 6.1k | 65.40 | |
| Pfizer (PFE) | 0.2 | $366k | 11k | 34.79 | |
| Amgen (AMGN) | 0.2 | $372k | 2.3k | 159.66 | |
| Merck & Co (MRK) | 0.2 | $380k | 6.6k | 57.49 | |
| Community Health Systems (CYH) | 0.2 | $321k | 6.1k | 52.24 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $281k | 5.7k | 49.47 | |
| Myriad Genetics (MYGN) | 0.1 | $277k | 7.8k | 35.42 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $226k | 1.7k | 134.93 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $213k | 5.1k | 41.60 |
